Tumor markers in stage P1 bladder cancer

dc.contributor.authorStavropoulos, N. E.en
dc.contributor.authorIoachim, E.en
dc.contributor.authorCharchanti, A.en
dc.contributor.authorMichael, M. C.en
dc.contributor.authorKitsiou, E.en
dc.contributor.authorMihailidis, I.en
dc.contributor.authorHastazeris, K.en
dc.contributor.authorAgnantis, N. J.en
dc.date.accessioned2015-11-24T19:03:20Z
dc.date.available2015-11-24T19:03:20Z
dc.identifier.issn0250-7005-
dc.identifier.urihttps://olympias.lib.uoi.gr/jspui/handle/123456789/19887
dc.rightsDefault Licence-
dc.subjectHumansen
dc.subjectKi-67 Antigen/*analysisen
dc.subjectNeoplasm Stagingen
dc.subjectProliferating Cell Nuclear Antigen/*analysisen
dc.subjectTumor Markers, Biological/*analysisen
dc.subjectTumor Suppressor Protein p53/*analysisen
dc.subjectUrinary Bladder Neoplasms/*chemistry/pathologyen
dc.titleTumor markers in stage P1 bladder canceren
heal.abstractBACKGROUND: The infiltration of muscularis mucosa in superficial bladder cancer has been reported to be predictive of an unfavourable course of the disease. MATERIALS AND METHODS: We studied immunohistochemically Ki-67, PCNA and p53 tumour markers in 68 P1a and Pib bladder tumours. RESULTS: A statistically significant difference (p = 0.01) was found in the distribution of grades between stages P1a and P1b, with more grade 3 and less grade 2 tumours in the latter category. Univariate analysis revealed a strong association of Ki-67 (p = 0.001) and PCNA (p = 0.032) only with stage. P53 protein expression did not have any significant association with either stage or grade. In 60 patients entered into the multivariate analysis a clearly predominant, significant effect of stage on Ki-67 (p = 0.000) was shown. CONCLUSION: Increased proliferative activity when compared to P1a is present in P1b bladder tumours, as detected by the increased expression of Ki-67 proliferating antigen. The immunohistochemical study of Ki-67 antigen may help in predicting stage P1 tumours' behaviour, even in cases where pathological distinction of P1a and P1b substages is difficult.en
heal.accesscampus-
heal.fullTextAvailabilityTRUE-
heal.identifier.secondaryhttp://www.ncbi.nlm.nih.gov/pubmed/11396238-
heal.journalNameAnticancer Resen
heal.journalTypepeer-reviewed-
heal.languageen-
heal.publicationDate2001-
heal.recordProviderΠανεπιστήμιο Ιωαννίνων. Σχολή Επιστημών Υγείας. Τμήμα Ιατρικήςel
heal.typejournalArticle-
heal.type.elΆρθρο Περιοδικούel
heal.type.enJournal articleen

Αρχεία

Φάκελος/Πακέτο αδειών

Προβολή: 1 - 1 of 1
Φόρτωση...
Μικρογραφία εικόνας
Ονομα:
license.txt
Μέγεθος:
1.74 KB
Μορφότυπο:
Item-specific license agreed upon to submission
Περιγραφή: